When these MED1-LxxLL mutant knockin mice were further crossed with a HER2-driven mammary tumor model (MMTV-HER2), it was found that MED1 LxxLL mutations were able to significantly delay the tumor onset, growth and metastasis[81]. Here, MED1 is linked to breast cancer.